10.1186/s12916-022-02599-4 179 WHO (2023)
Conversely, if you are on injections but struggling with side effects, switching to drops might provide adequate results with better tolerability
Pharmacological treatment of diabetic peripheral neuropathy: an update
The Indianapolis Big Pharma has teamed up with leading Alzheimer's experts at this year's Alzheimer Europe Conference to call for urgent improvements to diagnostic pathways to ensure people in Europe can benefit from new therapeutic innovation. #Lilly points to a recent survey, published in the Journal of Alzheimers Disease, that found 70% of clinicians believe biomarker tests, which can find evidence of Alzheimer's or dementia, are important or extremely important." Still, such tests remain "underutilized," according to Lilly's Oct
PMID: 12374906 Kossoy G et al
Caffeine and alcohol intake should also be assessed and potentially modified